Health ❯ Medicine

Cardiology

Heart Disease Heart Conditions Heart Surgery Regenerative Medicine Cardiac Arrest Cardiovascular Disease Heart Failure Hypertension Surgery Blood Pressure Management Heart Diseases Heart Health Cholesterol Cardiovascular Diseases Emergency Medicine Viral Infections Heart Anatomy Heart health Heart Problems High Blood Pressure Medical Procedures Cardiomyopathy Medical Testing Interventional Cardiology Cholesterol Management Peripheral Artery Disease Tissue Repair Cell Biology Cardiologists Cardiovascular Risk Gene Therapy Heart Drugs Heart Attack Doctor Heart Regeneration Cardiotoxicity Research Heart Ageing Medication Doses Vascular Inflammation Atrial Fibrillation Cardiovascular Risks Sudden Cardiac Arrest (SCA) Gender-Specific Health Issues Heart Rhythm Disorders Treatment

Low-Dose Colchicine Lowers Heart Attack and Stroke Risk in Heart Disease, Cochrane Review Finds

Clinicians frame the gout drug as a supervised secondary prevention option due to interaction risks.

Real-World Study Finds Semaglutide and Tirzepatide Cut Cardiovascular Risk in Type 2 Diabetes

AstraZeneca’s Baxdrostat Lowers 24-Hour Systolic BP by 14 mmHg in Phase 3, AHA Presentation Confirms

Reactivated Fetal Gene Triggers Division of Adult Human Heart Cells in Lab

FDA Clears UCLA’s ENPP1-Blocking Antibody AD-NP1 for First-in-Human Trial

Smooth Muscle lncRNA CARMN Identified as Therapeutic Target for Chronic Limb Ischemia

Baxdrostat Lowers Blood Pressure in Hard-to-Treat Patients in Phase III Trial

AstraZeneca’s Baxdrostat Lowers Blood Pressure in Phase III, Setting Up 2025 Filings

Boosting Apolipoprotein M Shows Promise Against Age-Related Macular Degeneration